A systematic approach to quantitative Western blot analysis.


Journal

Analytical biochemistry
ISSN: 1096-0309
Titre abrégé: Anal Biochem
Pays: United States
ID NLM: 0370535

Informations de publication

Date de publication:
15 03 2020
Historique:
received: 01 08 2019
revised: 16 12 2019
accepted: 27 01 2020
pubmed: 3 2 2020
medline: 13 1 2021
entrez: 3 2 2020
Statut: ppublish

Résumé

Attaining true quantitative data from WB requires that all the players involved in the procedure are quality controlled including the user. Appropriate protein extraction method, electrophoresis, and transfer of proteins, immunodetection of blotted protein by antibodies, and the ultimate step of imaging and analyzing the data is nothing short of a symphony. Like with any other technology in life-sciences research, Western blotting can produce erroneous and irreproducible data. We provide a systematic approach to generate quantitative data from Western blot experiments that incorporates critical validation steps to identify and minimize sources of error and variability throughout the Western blot process.

Identifiants

pubmed: 32007473
pii: S0003-2697(19)30750-X
doi: 10.1016/j.ab.2020.113608
pii:
doi:

Substances chimiques

Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

113608

Informations de copyright

Copyright © 2020 LI-COR BIOSCIENCES, LINCOLN, NEBRASKA 68504. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest L. Pillai-Kastoori, A. Schutz-Geschwender, and Jeff A. Harford are employees of LI-COR Biosciences.

Auteurs

Lakshmi Pillai-Kastoori (L)

LI-COR Biosciences, 4647 Superior Street, Lincoln, NE, 68504, USA. Electronic address: lakshmi.pillai@licor.com.

Amy R Schutz-Geschwender (AR)

LI-COR Biosciences, 4647 Superior Street, Lincoln, NE, 68504, USA.

Jeff A Harford (JA)

LI-COR Biosciences, 4647 Superior Street, Lincoln, NE, 68504, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH